Update Series (2024) Lesson 3: A Urologist's Guide to Administration of Checkpoint Inhibitors and Administration of Targeted Cancer Therapies in the Clinic

Audio Lessons - Listen on-the-go for Free!

Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?
Add the Update Series Audio Lessons to Your Podcast Library Today!

Please follow the download instructions to your preferred Podcast app, located below. 

Apple Podcasts 
1. Copy your Personal Subscriber Feed URL*: https://university.auanet.org/updateseries/rssaudio.cfm?userID=
2. Open Apple Podcasts app.
3. Click on "Library" on the bottom row of icons. 
4. Click "…" on the top right corner, and select "Add a Show by URL". 
5. Paste your copied personal URL and tap "Follow". 

Pocket Casts
1. Copy your Personal Subscriber Feed URL*: https://university.auanet.org/updateseries/rssaudio.cfm?userID=
2. Open Pocket Casts app.
3. On the “Discover” tab, paste your copied personal feed URL in the Search field and hit “Search”. 
4. Click on the Update Series Podcast in search results.
5. Click "Subscribe". 

*Please note that this URL is individual to you and only available to Update Series 2024 subscribers. 

Instructions to stream the Update Series in other Podcast apps
 

Access the Audio Lessons are also available in the AUAUniversity app and within the AUAU lesson Content page.

Download on the App StoreGet it on Google Play

Target Audience

  • Urologist
  • Resident

Learning Objectives

At the conclusion of this continuing medical education activity, the participant will be able to identify new systemic therapies available within nonmetastatic bladder and kidney cancer as well as metastatic prostate cancer, define barriers and benefits of in-practice administration of these agents, and implement organizational components to develop a safe and efficient advanced therapeutics program.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Course opens: 
01/01/2024
Course expires: 
12/31/2027
Rating: 
0

EDUCATION COUNCIL DISCLOSURES

PDF iconEducation Council Disclosures

COI REVIEW WORK GROUP DISCLOSURES

 PDF iconCOI Review Work Group Disclosures

UPDATE SERIES EDITORIAL COMMITTEE DISCLOSURES

PDF iconUpdate Series Editorial Committee

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

Author(s)

Gautam Jayram, MD

has a financial relationship (Consultant or Advisor (Oncology)) with Bristol Myers Squibb;.
has a financial relationship (Consultant or Advisor (Oncology)) with Tempus;.
has a financial relationship (Consultant or Advisor (Oncology)) with Merck;.
has a financial relationship (Consultant or Advisor (Oncology)) with Blue Earth;.
has a financial relationship (Consultant or Advisor (Oncology)) with Exact Sciences;.
has a financial relationship (Scientific Study or Trial (Oncology)) with Janssen;.
has a financial relationship (Consultant or Advisor (Oncology)) with AstraZeneca;.
has a financial relationship (Consultant or Advisor (Oncology)) with Photocure;.
has a financial relationship (Consultant or Advisor (Oncology)) with UroGPO;.

METHOD OF PARTICIPATION:

Participants receive 5 lessons per month for 8 months for a total of 40 lessons. Each lesson is designated for a maximum of 1.0 AMA PRA Category 1 Credit™. To earn credit, participants must read the educational material provided for each lesson, pass its corresponding online posttest with at least 80% accuracy, submit the online evaluation and claim CME.

ACCREDITATION:

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:

The American Urological Association designates this enduring material for a maximum of 40.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS:

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT:

 It is the policy of the AUA to ensure that the content contained in this CME enduring material activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest (aka ineligible company) during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation.

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

AUA PARTICIPANT INFORMATION & POLICIES

DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

REPRODUCTION PERMISSION:

Reproduction of written materials developed for this AUA activity is prohibited without the written permission from individual authors and the American Urological Association.

PEER REVIEW:

Peer review is the principle mechanism by which the quality of the AUA Update Series content is judged by the AUA Update Series Editorial Committee.

Released date: January, 2024
Expiration date: January, 2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Please login or register to take this course.

FACULTY DISCLOSURES AND ACCREDITATION

For specific faculty disclosure and accreditation information about this lesson, please go to the Faculty and Accreditation tabs.